Interestingly, TRPM1 was not directly linked to patients’ survival but to favorable pathological variables, such as Breslow’s depth and absence of ulceration, which is in line with other authors who defined TRPM1 loss as an excellent marker of melanoma aggressiveness [29,35,36]. Here, TRPM1 is linked to melanoma.